Daisuke Tanaka
About Daisuke Tanaka
Daisuke Tanaka is the Vice President of Exscientia Ltd in Japan, specializing in fragment-based drug discovery and medicinal chemistry. He holds a Ph.D. in synthetic organic chemistry from Hokkaido University and has extensive experience in the pharmaceutical industry.
Work at Exscientia
Daisuke Tanaka has been serving as Vice President for Exscientia Ltd in Japan since 2018. In this role, he focuses on advancing the company's initiatives in drug discovery and development. His leadership contributes to the integration of innovative technologies in the pharmaceutical sector, particularly in Japan.
Education and Expertise
Daisuke Tanaka holds a Ph.D. in synthetic organic chemistry from Hokkaido University, where he studied from 2005. He also earned a master's degree in synthetic organic chemistry from Nagasaki University between 1991 and 1993. Additionally, he studied at Harvard University from 2001 to 2003, further enhancing his expertise in the field. His specialization includes fragment-based drug discovery and palladium-catalyzed reactions, along with a strong background in medicinal chemistry.
Background
Daisuke Tanaka's academic journey began at Yamaguchi University, where he studied chemistry from 1987 to 1991. Following his education, he worked at Dainippon Sumitomo Pharma as Director from 2014 to 2018. His extensive background in both academia and industry has shaped his approach to drug discovery and development.
Professional Experience
Before joining Exscientia, Daisuke Tanaka held the position of Director at Dainippon Sumitomo Pharma for four years, from 2014 to 2018. His experience in this role provided him with insights into pharmaceutical operations and strategic development, which he applies in his current position.